Alkem Arise Online Quiz December'17

The correct answer is Esomeprazole 40 mg + Domperidone 30 mg SR Capsule. This is because the composition of Esokem D is mentioned as Esomeprazole 40 mg + Domperidone 30 mg SR Capsule in the given options.

Esokem-L is available as Dual Pellets, which means that it is formulated in the form of pellets. The term "dual" suggests that it contains two active ingredients or components. This form of medication is designed to release the active ingredients in a controlled manner, providing a sustained release of the medication over a longer period of time. The availability of Esokem-L as Dual Pellets provides patients with an option for convenient and effective treatment.

UBBC 07 is the correct answer because it suggests that Novogermina has the ability to withstand a temperature of 55 degrees Celsius. This indicates that Novogermina has a high heat tolerance and can maintain its stability and effectiveness even at high temperatures.

The indication of Esokem-L is in Functional Dyspepsia & Refractory GERD. This means that Esokem-L is recommended for use in patients who have functional dyspepsia, which is a condition characterized by recurring indigestion and pain in the upper abdomen, and also in patients who have refractory GERD, which refers to gastroesophageal reflux disease that does not respond to standard treatment. Esokem-L may help alleviate symptoms and provide relief in these conditions.

The indication of Esokem-D is in GERD & Dyspepsia associated with Nausea & Vomiting. This means that Esokem-D is recommended for the treatment of gastroesophageal reflux disease (GERD) and dyspepsia (indigestion) that is accompanied by symptoms of nausea and vomiting. It may not be effective or recommended for other conditions such as functional dyspepsia, refractory GERD, APDs, gastritis, or hyper-acidity.

The statement suggests that the Dual Coating of Esokem-L guarantees that there will be no degradation. This means that the coating is designed to protect the material from any form of deterioration or damage, ensuring its quality and performance over time.

The punch line "An Ideal PPI that Completes your Prescription" is applicable to all three options: Esokem, Esokem-D, and Esokem-L. This suggests that all these products are considered ideal proton pump inhibitors (PPIs) that can effectively complete a prescription.

The correct answer is Esomeprazole 40 mg + Levosulpiride 75 mg SR Capsule. This is because the composition of Esokem L is a combination of Esomeprazole and Levosulpiride in a sustained-release capsule form, with Esomeprazole at a dosage of 40 mg and Levosulpiride at a dosage of 75 mg. The other options listed do not match this specific composition.

not-available-via-ai

The correct answer is "Higher Glucose Breath normalization rate & decontamination rate". This means that Rifakem offers a higher rate of normalizing glucose breath levels and a higher rate of decontamination. This suggests that Rifakem is effective in reducing glucose levels in the breath and in removing contaminants.

INTEL Technology in Esokem-L ensures that the release of Esomeprazole pellets occurs primarily in the duodenum. This means that a majority of the medication is released in the duodenum, which is the first part of the small intestine, rather than in the stomach. This targeted release helps to optimize the absorption and effectiveness of the medication in the intended area of the digestive system.

Esomeprazole, which is available as Dual Pellets in the form of Esokem-L, is blue in color.

The correct answer is "Protects against moisture". The Esokem-L Inner coating, which contains Hypromellose Sodium, acts as a barrier that protects the medication from moisture. This is important because moisture can affect the stability and effectiveness of the medication. By preventing moisture from reaching the drug, the coating helps to maintain its quality and potency.

Levosulpiride, which is available as Dual Pellets under the brand name Esokem-L, is white in color.

Rifaximin acts by binding to the beta sub-unit of bacterial DNA dependent RNA polymerase. This binding prevents the enzyme from synthesizing RNA, leading to the inhibition of bacterial RNA synthesis. As a result, the bacteria are unable to produce essential proteins and ultimately cannot survive or replicate. This mechanism of action makes rifaximin an effective antibiotic for treating bacterial infections.

Esokem is indicated for the treatment of APDs (Acid Peptic Disorders) such as gastritis and hyperacidity. This means that Esokem is used to alleviate symptoms related to excessive acid production in the stomach, including conditions like gastritis and hyperacidity. It is not indicated for functional dyspepsia, refractory GERD, or GERD and dyspepsia associated with nausea and vomiting.

The correct answer is "Both (a) & (b)". The outer EAMA coating in Esokem-L provides protection against the acidic medium of the stomach, as well as being totally non-permeable to stomach acid. Additionally, it also protects against moisture. Therefore, both options (a) and (b) are correct.

The correct answer is "Stomach." This means that the INTEL Technology in Esokem-L ensures that Levosulpiride SR pellets are released primarily in the stomach.

The given statement is "Esokem-L Capsule Shell is Translucent" and the correct answer is "False." This means that the Esokem-L capsule shell is not translucent.

Rifakem is classified as a non-aminoglycoside semi-synthetic, non-systemic antibiotic. This means that it is a type of antibiotic that is not derived from the aminoglycoside class of drugs. It is also a semi-synthetic antibiotic, which means that it is partially synthesized in the laboratory using natural or semi-synthetic compounds. Additionally, Rifakem is non-systemic, meaning that it does not have a widespread effect throughout the body and is typically used to treat localized infections.